"10.1371_journal.pone.0050098","plos one","2012-11-21T00:00:00Z","Arindam Banerjee; Zheng-Sheng Wu; Peng-Xu Qian; Jian Kang; Dong-Xu Liu; Tao Zhu; Peter E Lobie","Liggins Institute, University of Auckland, Auckland, New Zealand; Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, Peoples Republic of China; Department of Pathology, Anhui Medical University, Hefei, Anhui, Peoples Republic of China; Department of Pathology, Shanghai Medical College, Fudan University, Shanghai, Peoples Republic of China; Cancer Science Institute of Singapore and Department of Pharmacology, National University of Singapore, Singapore, Singapore","Conceived and designed the experiments: AB PEL. Performed the experiments: AB ZSW PXQ JK. Analyzed the data: AB ZSW PXQ DXL TZ PEL. Wrote the paper: AB PEL.","DXL and PEL are inventors on PCT/NZ2008/000152. PEL is an inventor on PCT/NZ2010/000207. ZT and PEL have equity interest in Li Kang Therapeutics Ltd. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2012","11","Arindam Banerjee","AB",7,TRUE,2,4,6,2,TRUE,TRUE,FALSE,0,NA,FALSE
